Pathogenic alteration frequency by EUS FNA in malignant lymph node

Ferga C. Gleeson, MD, from the Division of Gastroenterology and Hepatology, Mayo Clinic, in Rochester, Minnesota, USA discusses this Original Article, "Frequency of mitogen-activated protein kinase and phosphoinositide 3-kinase signaling pathway pathogenic alterations in EUS-FNA sampled malignant lymph nodes in rectal cancer with theranostic potential." We have previously characterized EUS FNA cytology specimens by targeted …

Continue reading Pathogenic alteration frequency by EUS FNA in malignant lymph node